Novartis
Some Concerns about the Amendment Process to Key Patent Levers: A “Captured” Patent Office?
Source Node: 2521230
Time Stamp: Mar 21, 2024
A Patent System’s Job is to Incentivize More Innovation, Not Merely More Patents: Looking at the New Patent (Amendment) Rules- Part II
Source Node: 2521232
Time Stamp: Mar 20, 2024
Paris-based cybertech Filigran raises €15 million Series A to expand its open source threat intelligence platform | EU-Startups
Source Node: 2499751
Time Stamp: Feb 29, 2024
AstraZeneca, Atlassian and Philips: How to convince suppliers to lower greenhouse gas emissions | GreenBiz
Source Node: 2460637
Time Stamp: Jan 29, 2024
Intellectual Property as a Catalyst: Promoting Inclusiveness, Empowerment, and Development
Source Node: 2452470
Time Stamp: Jan 22, 2024
Alphabet’s Isomorphic Secures Lucrative Pharma Deals Worth Nearly $3 Billion
Source Node: 2432589
Time Stamp: Jan 8, 2024
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2023 Global Net Product Revenues and Provides Additional Updates
Source Node: 2432452
Time Stamp: Jan 7, 2024
USA Solid Tumor Therapeutics Market Outlook to 2028 – Field of Oncology is Moving Towards more Personalized Treatment – ResearchAndMarkets.com
Source Node: 2416082
Time Stamp: Dec 26, 2023
Drugmakers Argue Double Patenting Ruling Defies Congress – Law360
Source Node: 2403136
Time Stamp: Nov 28, 2023
How to Give AI a ‘Gut Feeling’ for Which Molecules Will Make the Best Drugs
Source Node: 2364825
Time Stamp: Nov 3, 2023
Time to look Beyond Compulsory Licenses? A Glimpse at the Ribociclib Case
Source Node: 2359308
Time Stamp: Oct 31, 2023
Climate Change Drives Net-zero Leaders In The Pharmaceutical Industry – Carbon Credit Capital
Source Node: 2357014
Time Stamp: Oct 30, 2023
Net Zero Leaders In The Pharmaceutical Industry – Carbon Credit Capital
Source Node: 2376492
Time Stamp: Oct 30, 2023
Week Ahead – ECB set to pause tightening cycle, a big week for earnings – MarketPulse
Source Node: 2340207
Time Stamp: Oct 20, 2023